dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Philippe Sarrabayrouse, Guillaume |
dc.contributor.author | Elias Vidal, Andrea |
dc.contributor.author | Yañez Araya, Francisca |
dc.contributor.author | Mayorga Ayala, Luis Fernando |
dc.contributor.author | Bartoli, Chiara |
dc.contributor.author | Casellas Jordá, Francesc |
dc.contributor.author | Borruel Sainz, Natalia |
dc.contributor.author | Herrera de Guise, Claudia Maria |
dc.contributor.author | Manichanh, Chaysavanh |
dc.contributor.author | Varela Castro, Encarna |
dc.date.accessioned | 2022-03-30T09:04:44Z |
dc.date.available | 2022-03-30T09:04:44Z |
dc.date.issued | 2021-03 |
dc.identifier.citation | Sarrabayrouse G, Elias A, Yáñez F, Mayorga L, Varela E, Bartoli C, et al. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting. mSystems. 2021 Mar;6(2):e01277-20. |
dc.identifier.issn | 2379-5077 |
dc.identifier.uri | https://hdl.handle.net/11351/7274 |
dc.description | Malaltia inflamatòria intestinal; Càrrega microbiana; Predicció |
dc.description.sponsorship | This work was funded by Instituto de Salud Carlos III, grant PI17/00614, cofinanced by the European Regional Development Fund (ERDF) and by the PERIS (SLT002/16). F. Casellas has received research funding from AbbVie, Ferring, MSD, Shire, and Zambon and speaker fees from AbbVie, Chiesi, Ferring, Gebro, MSD, Shire, Takeda, and Zambon. S. Vermeire has received grant support from AbbVie, MSD, Pfizer, J&J, and Takeda; received speaker fees from AbbVie, MSD, Takeda, Ferring, Dr. Falk Pharma, Hospira, Pfizer Inc., and Tillots; and served as a consultant for AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Robarts clinical trials, Gilead, Celgene, Prometheus, Avaxia, Prodigest, Shire, Pfizer Inc, Galapagos, Mundipharma, Hospira, Celgene, Second Genome, and Janssen. C. Manichanh has received financial support for research from Danone. |
dc.language.iso | eng |
dc.publisher | American Society for Microbiology |
dc.relation.ispartofseries | mSystems;6(2) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Intestins - Inflamació |
dc.subject | Intestins - Microbiologia |
dc.subject | Intestins - Malalties - Prognosi |
dc.subject.mesh | Crohn Disease |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Prognosis |
dc.subject.mesh | Bacterial Load |
dc.title | Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1128/mSystems.01277-20 |
dc.subject.decs | enfermedad de Crohn |
dc.subject.decs | /diagnóstico |
dc.subject.decs | pronóstico |
dc.subject.decs | carga bacteriana |
dc.relation.publishversion | https://doi.org/10.1128/mSystems.01277-20 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sarrabayrouse G, Elias A, Yáñez F, Mayorga L, Bartoli C, Herrera de Guise C] Servei de Gastroenterologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Varela E, Casellas F, Borruel N, Manichanh C] Servei de Gastroenterologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERehd, Instituto de Salud Carlos III, Madrid, Spain |
dc.identifier.pmid | 33758031 |
dc.identifier.wos | 000665831100009 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI17%2F00614 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002/16 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |